{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:58:56Z","timestamp":1769162336872,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.transproceed.2022.12.003","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T15:23:07Z","timestamp":1672327387000},"page":"93-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Reduction in Maintenance Immunosuppression in Kidney Transplant Recipients With Stable Donor-Derived Cell-Free DNA Measurements: A Case Series"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-8225","authenticated-orcid":false,"given":"Erik L.","family":"Lum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arta","family":"Towns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debargha","family":"Basuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong-Thu","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinalini","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suphamai","family":"Bunnapradist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.12.003_bib0001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQITM) conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/TP.0000000000002482","article-title":"Donor-specific cell-free DNA as a biomarker in solid organ transplantation. A systematic review","volume":"103","author":"Knight","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0003","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0004","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.932249","article-title":"Clinical rationale for a routine testing schedule using donor-derived cell-free DNA after kidney transplantation","volume":"26","author":"Pai","year":"2021","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0006","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","article-title":"Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection","volume":"69","author":"Marc\u00e9n","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0007","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TP.0b013e3181fdd96c","article-title":"Increasing trend in infection-related death-censored graft failure in renal transplantation","volume":"91","author":"Parasuraman","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0008","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2215\/CJN.14570920","article-title":"De novo malignancies after kidney transplantation","volume":"17","author":"Al-Adra","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0009","first-page":"208","article-title":"Immunosuppressive drugs and associated complications in abdominal organ transplantation","volume":"28","author":"Olson","year":"2022","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.rcl.2015.09.009","article-title":"Complications of immunosuppressive therapy in solid organ transplantation","volume":"54","author":"Katabathina","year":"2016","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12882-020-01739-3","article-title":"Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients","volume":"21","author":"Phanish","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0012","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/tri.12570","article-title":"Immunological risks of minimization strategies","volume":"28","author":"Snanoudj","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12916-016-0772-6","article-title":"Steroid withdrawal after renal transplantation: a retrospective cohort study","volume":"15","author":"Haller","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0015","first-page":"149","article-title":"Outcomes of late corticosteroid withdrawal after renal transplantation in patients exposed to tacrolimus and\/or mycophenolate mofetil: meta-analysis of randomized controlled trials","volume":"2","author":"Ali","year":"2011","journal-title":"Int J Organ Transplant Med"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0016","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0b013e318186f98a","article-title":"Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial","volume":"86","author":"van Gelder","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0017","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.1600-6143.2009.02668.x","volume":"9","author":"Gaston","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.12.003_bib0018","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1600-6143.2003.00079.x","article-title":"Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies","volume":"3","author":"Shaw","year":"2003","journal-title":"Am J Transpl"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452200879X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452200879X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:45:24Z","timestamp":1758577524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113452200879X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S004113452200879X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.12.003","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction in Maintenance Immunosuppression in Kidney Transplant Recipients With Stable Donor-Derived Cell-Free DNA Measurements: A Case Series","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}